chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Abdominal pain upper, Fatigue, Headache, Malaise
Clinical narrative: activation of a long dormant (over 12 years) auto-immune disorder, bullous pemphigus; day 5-8 was intense GI distress with stabbing stomach pain; day 5-8 was intense GI distress with stabbing stomach pain; general malaise; Day 1-4 was significant fatigue and headache; Day 1-4 was significant fatigue and headache; This is a spontaneous report from a contactable consumer. A 58-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration on 14Jan2021 at 10:00 at a single dose on right arm for COVID-19 immunisation. Medical history included high cholesterol, blood pressure abnormal, degenerative arthritis and allergies to penicillin and NSAIDS. Concomitant medications included gabapentin, lisinopril, levothyroxine and atorvastatin. On days 1-4, the patient experienced significant fatigue and headache on 15Jan2021. On days 5-8, there was intense GI distress with stabbing stomach pain, following these events has been continued with fatigue and general malaise. Most problematic was activation of a long dormant (over 12 years) auto-immune disorder, bullous pemphigus, which attacks soft tissue areas on the body with blisters and sloughing skin. This is a very uncomfortable experience to go through. The patient's healthcare provider is aware and treating him for such. The patient underwent lab tests and procedures which included SARS-COV-2 test: negative on 25Jan2021. Therapeutic measures were taken as a result of day 1-4 was significant fatigue and headache, day 5-8 was intense gi distress with stabbing stomach pain and general malaise. The outcome of the events was not recovered.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pemphigoid, SARS-CoV-2 test
Clinical narrative: activation of a long dormant (over 12 years) auto-immune disorder, bullous pemphigus; day 5-8 was intense GI distress with stabbing stomach pain; day 5-8 was intense GI distress with stabbing stomach pain; general malaise; Day 1-4 was significant fatigue and headache; Day 1-4 was significant fatigue and headache; This is a spontaneous report from a contactable consumer. A 58-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration on 14Jan2021 at 10:00 at a single dose on right arm for COVID-19 immunisation. Medical history included high cholesterol, blood pressure abnormal, degenerative arthritis and allergies to penicillin and NSAIDS. Concomitant medications included gabapentin, lisinopril, levothyroxine and atorvastatin. On days 1-4, the patient experienced significant fatigue and headache on 15Jan2021. On days 5-8, there was intense GI distress with stabbing stomach pain, following these events has been continued with fatigue and general malaise. Most problematic was activation of a long dormant (over 12 years) auto-immune disorder, bullous pemphigus, which attacks soft tissue areas on the body with blisters and sloughing skin. This is a very uncomfortable experience to go through. The patient's healthcare provider is aware and treating him for such. The patient underwent lab tests and procedures which included SARS-COV-2 test: negative on 25Jan2021. Therapeutic measures were taken as a result of day 1-4 was significant fatigue and headache, day 5-8 was intense gi distress with stabbing stomach pain and general malaise. The outcome of the events was not recovered.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acidosis, Anaemia, Analgesic drug level decreased, Anxiety, Bacterial test negative
Clinical narrative: Person received Covid vaccine on 2/3/21 at 1620 at an off site Shelter.  On 2/4/21 person was at a Detox center.  She was being monitored and treated for alcohol withdrawal symptoms.  She was given Chlordiazepoxide as part of management of withdrawal.  On 2/4/21 in the evening she was stable throught the day.  Then at approximately 6:45 pm, she had seizure-like event.  Local 911 were called as she had become pulseless.  She was brought to the hospital for continued resuscitation.  She never regained consciousness and died 2/5/21 at 0248.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Basophil percentage increased, Bilirubin urine, Blood bicarbonate decreased, Blood gases, Blood magnesium decreased
Clinical narrative: Person received Covid vaccine on 2/3/21 at 1620 at an off site Shelter.  On 2/4/21 person was at a Detox center.  She was being monitored and treated for alcohol withdrawal symptoms.  She was given Chlordiazepoxide as part of management of withdrawal.  On 2/4/21 in the evening she was stable throught the day.  Then at approximately 6:45 pm, she had seizure-like event.  Local 911 were called as she had become pulseless.  She was brought to the hospital for continued resuscitation.  She never regained consciousness and died 2/5/21 at 0248.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pH decreased, Blood smear test, Blood urine absent, Bradycardia, Brain oedema
Clinical narrative: Person received Covid vaccine on 2/3/21 at 1620 at an off site Shelter.  On 2/4/21 person was at a Detox center.  She was being monitored and treated for alcohol withdrawal symptoms.  She was given Chlordiazepoxide as part of management of withdrawal.  On 2/4/21 in the evening she was stable throught the day.  Then at approximately 6:45 pm, she had seizure-like event.  Local 911 were called as she had become pulseless.  She was brought to the hospital for continued resuscitation.  She never regained consciousness and died 2/5/21 at 0248.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiac arrest, Cardio-respiratory arrest, Chromaturia, Computerised tomogram head abnormal, Crystal urine absent
Clinical narrative: Person received Covid vaccine on 2/3/21 at 1620 at an off site Shelter.  On 2/4/21 person was at a Detox center.  She was being monitored and treated for alcohol withdrawal symptoms.  She was given Chlordiazepoxide as part of management of withdrawal.  On 2/4/21 in the evening she was stable throught the day.  Then at approximately 6:45 pm, she had seizure-like event.  Local 911 were called as she had become pulseless.  She was brought to the hospital for continued resuscitation.  She never regained consciousness and died 2/5/21 at 0248.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Culture urine, Death, Drug screen negative, Endotracheal intubation, Eosinophil percentage increased
Clinical narrative: Person received Covid vaccine on 2/3/21 at 1620 at an off site Shelter.  On 2/4/21 person was at a Detox center.  She was being monitored and treated for alcohol withdrawal symptoms.  She was given Chlordiazepoxide as part of management of withdrawal.  On 2/4/21 in the evening she was stable throught the day.  Then at approximately 6:45 pm, she had seizure-like event.  Local 911 were called as she had become pulseless.  She was brought to the hospital for continued resuscitation.  She never regained consciousness and died 2/5/21 at 0248.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fibrin D dimer increased, Gastrointestinal haemorrhage, Glucose urine absent, Haematocrit decreased, Haemoglobin decreased
Clinical narrative: Person received Covid vaccine on 2/3/21 at 1620 at an off site Shelter.  On 2/4/21 person was at a Detox center.  She was being monitored and treated for alcohol withdrawal symptoms.  She was given Chlordiazepoxide as part of management of withdrawal.  On 2/4/21 in the evening she was stable throught the day.  Then at approximately 6:45 pm, she had seizure-like event.  Local 911 were called as she had become pulseless.  She was brought to the hospital for continued resuscitation.  She never regained consciousness and died 2/5/21 at 0248.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Head discomfort, Human chorionic gonadotropin negative, Hypoxia, International normalised ratio increased, Lymphocyte percentage decreased
Clinical narrative: Person received Covid vaccine on 2/3/21 at 1620 at an off site Shelter.  On 2/4/21 person was at a Detox center.  She was being monitored and treated for alcohol withdrawal symptoms.  She was given Chlordiazepoxide as part of management of withdrawal.  On 2/4/21 in the evening she was stable throught the day.  Then at approximately 6:45 pm, she had seizure-like event.  Local 911 were called as she had become pulseless.  She was brought to the hospital for continued resuscitation.  She never regained consciousness and died 2/5/21 at 0248.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mean cell haemoglobin decreased, Mean cell volume decreased, Mechanical ventilation, Monocyte percentage decreased, Musculoskeletal stiffness
Clinical narrative: Person received Covid vaccine on 2/3/21 at 1620 at an off site Shelter.  On 2/4/21 person was at a Detox center.  She was being monitored and treated for alcohol withdrawal symptoms.  She was given Chlordiazepoxide as part of management of withdrawal.  On 2/4/21 in the evening she was stable throught the day.  Then at approximately 6:45 pm, she had seizure-like event.  Local 911 were called as she had become pulseless.  She was brought to the hospital for continued resuscitation.  She never regained consciousness and died 2/5/21 at 0248.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neutrophil count normal, Nitrite urine absent, PCO2 normal, PO2 normal, Platelet count decreased
Clinical narrative: Person received Covid vaccine on 2/3/21 at 1620 at an off site Shelter.  On 2/4/21 person was at a Detox center.  She was being monitored and treated for alcohol withdrawal symptoms.  She was given Chlordiazepoxide as part of management of withdrawal.  On 2/4/21 in the evening she was stable throught the day.  Then at approximately 6:45 pm, she had seizure-like event.  Local 911 were called as she had become pulseless.  She was brought to the hospital for continued resuscitation.  She never regained consciousness and died 2/5/21 at 0248.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Poisoning, Protein urine absent, Prothrombin time prolonged, Pulse absent, Pulseless electrical activity
Clinical narrative: Person received Covid vaccine on 2/3/21 at 1620 at an off site Shelter.  On 2/4/21 person was at a Detox center.  She was being monitored and treated for alcohol withdrawal symptoms.  She was given Chlordiazepoxide as part of management of withdrawal.  On 2/4/21 in the evening she was stable throught the day.  Then at approximately 6:45 pm, she had seizure-like event.  Local 911 were called as she had become pulseless.  She was brought to the hospital for continued resuscitation.  She never regained consciousness and died 2/5/21 at 0248.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Red blood cell count decreased, Red blood cell nucleated morphology, Red blood cells urine positive, Red cell distribution width normal, Resuscitation
Clinical narrative: Person received Covid vaccine on 2/3/21 at 1620 at an off site Shelter.  On 2/4/21 person was at a Detox center.  She was being monitored and treated for alcohol withdrawal symptoms.  She was given Chlordiazepoxide as part of management of withdrawal.  On 2/4/21 in the evening she was stable throught the day.  Then at approximately 6:45 pm, she had seizure-like event.  Local 911 were called as she had become pulseless.  She was brought to the hospital for continued resuscitation.  She never regained consciousness and died 2/5/21 at 0248.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test negative, SARS-CoV-2 test positive, Seizure like phenomena, Specific gravity urine increased, Specific gravity urine normal
Clinical narrative: Person received Covid vaccine on 2/3/21 at 1620 at an off site Shelter.  On 2/4/21 person was at a Detox center.  She was being monitored and treated for alcohol withdrawal symptoms.  She was given Chlordiazepoxide as part of management of withdrawal.  On 2/4/21 in the evening she was stable throught the day.  Then at approximately 6:45 pm, she had seizure-like event.  Local 911 were called as she had become pulseless.  She was brought to the hospital for continued resuscitation.  She never regained consciousness and died 2/5/21 at 0248.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sulphur dioxide test, Syncope, Troponin I increased, Urinary sediment present, Urine abnormality
Clinical narrative: Person received Covid vaccine on 2/3/21 at 1620 at an off site Shelter.  On 2/4/21 person was at a Detox center.  She was being monitored and treated for alcohol withdrawal symptoms.  She was given Chlordiazepoxide as part of management of withdrawal.  On 2/4/21 in the evening she was stable throught the day.  Then at approximately 6:45 pm, she had seizure-like event.  Local 911 were called as she had become pulseless.  She was brought to the hospital for continued resuscitation.  She never regained consciousness and died 2/5/21 at 0248.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urine ketone body absent, Urine leukocyte esterase, Urobilinogen urine decreased, White blood cell count normal, White blood cells urine positive
Clinical narrative: Person received Covid vaccine on 2/3/21 at 1620 at an off site Shelter.  On 2/4/21 person was at a Detox center.  She was being monitored and treated for alcohol withdrawal symptoms.  She was given Chlordiazepoxide as part of management of withdrawal.  On 2/4/21 in the evening she was stable throught the day.  Then at approximately 6:45 pm, she had seizure-like event.  Local 911 were called as she had become pulseless.  She was brought to the hospital for continued resuscitation.  She never regained consciousness and died 2/5/21 at 0248.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: pH urine normal
Clinical narrative: Person received Covid vaccine on 2/3/21 at 1620 at an off site Shelter.  On 2/4/21 person was at a Detox center.  She was being monitored and treated for alcohol withdrawal symptoms.  She was given Chlordiazepoxide as part of management of withdrawal.  On 2/4/21 in the evening she was stable throught the day.  Then at approximately 6:45 pm, she had seizure-like event.  Local 911 were called as she had become pulseless.  She was brought to the hospital for continued resuscitation.  She never regained consciousness and died 2/5/21 at 0248.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alcohol withdrawal syndrome, Death, Pulse absent, Resuscitation, Seizure like phenomena
Clinical narrative: Person received Covid vaccine on 2/3/21 at 1620 at an off site Shelter.  On 2/4/21 person was at a Detox center.  She was being monitored and treated for alcohol withdrawal symptoms.  She was given Chlordiazepoxide as part of management of withdrawal.  On 2/4/21 in the evening she was stable throught the day.  Then at approximately 6:45 pm, she had seizure-like event.  Local 911 were called as she had become pulseless.  She was brought to the hospital for continued resuscitation.  She never regained consciousness and died 2/5/21 at 0248.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Paraesthesia, Sleep disorder
Clinical narrative: Paresthesias in feet and hands, strongest in the left hand; This is a spontaneous report from a contactable physician (patient). A non-pregnant 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EJ1685), via an unspecified route of administration in left arm, on 19Dec2020 at 09:30 AM, at a single dose, for COVID-19 immunization. The patient's medical history included tinnitus, intermittent vertigo, and non-anaphylactic allergy to egg.  There were no concomitant medications. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The most recent COVID-19 vaccine was administered in a hospital facility. On 26Dec2020, the patient experienced paresthesias in feet and hands, strongest in the left hand. The event was considered non-serious. No treatment was received for the adverse event. The patient was administered with the second dose of BNT162B2 (Lot Number: EJ1283) on 09Jan2021 at 09:30 AM in left arm. Since the vaccination, the patient has not been tested for COVID-19. The patient had not recovered from the event.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: Paresthesias in feet and hands, strongest in the left hand; This is a spontaneous report from a contactable physician (patient). A non-pregnant 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EJ1685), via an unspecified route of administration in left arm, on 19Dec2020 at 09:30 AM, at a single dose, for COVID-19 immunization. The patient's medical history included tinnitus, intermittent vertigo, and non-anaphylactic allergy to egg.  There were no concomitant medications. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The most recent COVID-19 vaccine was administered in a hospital facility. On 26Dec2020, the patient experienced paresthesias in feet and hands, strongest in the left hand. The event was considered non-serious. No treatment was received for the adverse event. The patient was administered with the second dose of BNT162B2 (Lot Number: EJ1283) on 09Jan2021 at 09:30 AM in left arm. Since the vaccination, the patient has not been tested for COVID-19. The patient had not recovered from the event.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Feeling hot, Heart rate increased, Hypertension, Immediate post-injection reaction
Clinical narrative: pain in the left scapula area; a sensation of her body "vibrating" down the left arm; I felt: hot, a water dripping sensation inside my left arm; elevated BP; elevated pulse; elevated respirations; This is a spontaneous report from a contactable consumer (patient). A 39-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EJ1686), via an unspecified route of administration on 18Jan2021 09:00 in left arm, at single dose for covid-19 immunization. Medical history included known allergies: Latex and causes a rash. Concomitant drugs included women's 1 a day multi-vitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Immediately after administration of the Covid-19 Vaccine on 18Jan2021, the patient felt: hot, a water dripping sensation inside my left arm, elevated BP, elevated pulse, and elevated respirations. On 22Jan2021 02:00 the first morning she noticed pain in the left scapula area, and a sensation of her body "vibrating" down the left arm. Each day the "vibrations" have worsened from 1 arm, to both arms, to up and down her spine, to up her neck, and some days even her face. She got NO relief from the "vibrations". They are constant 24 hours a day. She had been to the chiropractor, urgent care, and the ER. She had physician consults, blood work, x-rays, and CT Scan. It is effecting her life. She had NO relief, and got answers that she just had anxiety. This is not just anxiety. There is something wrong with her, and the only change in her life, has been to receive her covid vaccine. Medications have been given to help mask the symptoms, but they are still present, and are never changing or ending. Events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care and considered as disability condition. No treatment was received for events (except event a sensation of her body "vibrating" down the left arm) The outcome of the events was not recovered. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test, Respiratory rate increased, Sensory disturbance, Vibratory sense increased, X-ray
Clinical narrative: pain in the left scapula area; a sensation of her body "vibrating" down the left arm; I felt: hot, a water dripping sensation inside my left arm; elevated BP; elevated pulse; elevated respirations; This is a spontaneous report from a contactable consumer (patient). A 39-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EJ1686), via an unspecified route of administration on 18Jan2021 09:00 in left arm, at single dose for covid-19 immunization. Medical history included known allergies: Latex and causes a rash. Concomitant drugs included women's 1 a day multi-vitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Immediately after administration of the Covid-19 Vaccine on 18Jan2021, the patient felt: hot, a water dripping sensation inside my left arm, elevated BP, elevated pulse, and elevated respirations. On 22Jan2021 02:00 the first morning she noticed pain in the left scapula area, and a sensation of her body "vibrating" down the left arm. Each day the "vibrations" have worsened from 1 arm, to both arms, to up and down her spine, to up her neck, and some days even her face. She got NO relief from the "vibrations". They are constant 24 hours a day. She had been to the chiropractor, urgent care, and the ER. She had physician consults, blood work, x-rays, and CT Scan. It is effecting her life. She had NO relief, and got answers that she just had anxiety. This is not just anxiety. There is something wrong with her, and the only change in her life, has been to receive her covid vaccine. Medications have been given to help mask the symptoms, but they are still present, and are never changing or ending. Events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care and considered as disability condition. No treatment was received for events (except event a sensation of her body "vibrating" down the left arm) The outcome of the events was not recovered. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Blood pressure increased, Blood pressure measurement, Computerised tomogram, Feeling hot
Clinical narrative: pain in the left scapula area; a sensation of her body "vibrating" down the left arm; I felt: hot, a water dripping sensation inside my left arm; elevated BP; elevated pulse; elevated respirations; This is a spontaneous report from a contactable consumer (patient). A 39-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EJ1686), via an unspecified route of administration on 18Jan2021 09:00 in left arm, at single dose for covid-19 immunization. Medical history included known allergies: Latex and causes a rash. Concomitant drugs included women's 1 a day multi-vitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Immediately after administration of the Covid-19 Vaccine on 18Jan2021, the patient felt: hot, a water dripping sensation inside my left arm, elevated BP, elevated pulse, and elevated respirations. On 22Jan2021 02:00 the first morning she noticed pain in the left scapula area, and a sensation of her body "vibrating" down the left arm. Each day the "vibrations" have worsened from 1 arm, to both arms, to up and down her spine, to up her neck, and some days even her face. She got NO relief from the "vibrations". They are constant 24 hours a day. She had been to the chiropractor, urgent care, and the ER. She had physician consults, blood work, x-rays, and CT Scan. It is effecting her life. She had NO relief, and got answers that she just had anxiety. This is not just anxiety. There is something wrong with her, and the only change in her life, has been to receive her covid vaccine. Medications have been given to help mask the symptoms, but they are still present, and are never changing or ending. Events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care and considered as disability condition. No treatment was received for events (except event a sensation of her body "vibrating" down the left arm) The outcome of the events was not recovered. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate, Heart rate increased, Investigation, Paraesthesia, Respiratory rate
Clinical narrative: pain in the left scapula area; a sensation of her body "vibrating" down the left arm; I felt: hot, a water dripping sensation inside my left arm; elevated BP; elevated pulse; elevated respirations; This is a spontaneous report from a contactable consumer (patient). A 39-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EJ1686), via an unspecified route of administration on 18Jan2021 09:00 in left arm, at single dose for covid-19 immunization. Medical history included known allergies: Latex and causes a rash. Concomitant drugs included women's 1 a day multi-vitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Immediately after administration of the Covid-19 Vaccine on 18Jan2021, the patient felt: hot, a water dripping sensation inside my left arm, elevated BP, elevated pulse, and elevated respirations. On 22Jan2021 02:00 the first morning she noticed pain in the left scapula area, and a sensation of her body "vibrating" down the left arm. Each day the "vibrations" have worsened from 1 arm, to both arms, to up and down her spine, to up her neck, and some days even her face. She got NO relief from the "vibrations". They are constant 24 hours a day. She had been to the chiropractor, urgent care, and the ER. She had physician consults, blood work, x-rays, and CT Scan. It is effecting her life. She had NO relief, and got answers that she just had anxiety. This is not just anxiety. There is something wrong with her, and the only change in her life, has been to receive her covid vaccine. Medications have been given to help mask the symptoms, but they are still present, and are never changing or ending. Events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care and considered as disability condition. No treatment was received for events (except event a sensation of her body "vibrating" down the left arm) The outcome of the events was not recovered. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Respiratory rate increased, X-ray
Clinical narrative: pain in the left scapula area; a sensation of her body "vibrating" down the left arm; I felt: hot, a water dripping sensation inside my left arm; elevated BP; elevated pulse; elevated respirations; This is a spontaneous report from a contactable consumer (patient). A 39-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EJ1686), via an unspecified route of administration on 18Jan2021 09:00 in left arm, at single dose for covid-19 immunization. Medical history included known allergies: Latex and causes a rash. Concomitant drugs included women's 1 a day multi-vitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Immediately after administration of the Covid-19 Vaccine on 18Jan2021, the patient felt: hot, a water dripping sensation inside my left arm, elevated BP, elevated pulse, and elevated respirations. On 22Jan2021 02:00 the first morning she noticed pain in the left scapula area, and a sensation of her body "vibrating" down the left arm. Each day the "vibrations" have worsened from 1 arm, to both arms, to up and down her spine, to up her neck, and some days even her face. She got NO relief from the "vibrations". They are constant 24 hours a day. She had been to the chiropractor, urgent care, and the ER. She had physician consults, blood work, x-rays, and CT Scan. It is effecting her life. She had NO relief, and got answers that she just had anxiety. This is not just anxiety. There is something wrong with her, and the only change in her life, has been to receive her covid vaccine. Medications have been given to help mask the symptoms, but they are still present, and are never changing or ending. Events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care and considered as disability condition. No treatment was received for events (except event a sensation of her body "vibrating" down the left arm) The outcome of the events was not recovered. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Back pain, Headache, Mobility decreased, Neck pain
Clinical narrative: Sore arm; neck pain; radiated to shoulder; radiated to back toward backbone, then up back; headache; This is a spontaneous report from a contactable consumer reporting for herself. A 69-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL9263 and expiry date unknown) on 26Jan2021 18:00 at single does via an unspecified route of administration into her left arm for COVID-19 immunization. Medical history included Lupus, Lyme disease, hypothyroid, Meniere's, and sulfa allergies. The patient had not had COVID prior the vaccination, COVID not tested post the vaccination. Concomitant medication included levothyroxine (LEVOTHYROXINE), acyclovir (ACYCLOVIR), ezetimibe (EZETIMIBE), hydroxychloroquine (HYDROXYCHLOROQUINE). No other vaccine received in four weeks. The patient experienced adverse events from 20:00 on 26Jan2021. She experienced sore arm, radiated to shoulder, then to back toward backbone, then up back and side of neck. It's very painful. On 07Feb2021 ("today"), her neck pain was better but she had a headache. These events took place ongoing for several days after and since she had the vaccine. It was reported that the events resulted in Disability or permanent damage. The patient did not receive treatment for the events. The outcome of the events was provided as recovering.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Sore arm; neck pain; radiated to shoulder; radiated to back toward backbone, then up back; headache; This is a spontaneous report from a contactable consumer reporting for herself. A 69-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL9263 and expiry date unknown) on 26Jan2021 18:00 at single does via an unspecified route of administration into her left arm for COVID-19 immunization. Medical history included Lupus, Lyme disease, hypothyroid, Meniere's, and sulfa allergies. The patient had not had COVID prior the vaccination, COVID not tested post the vaccination. Concomitant medication included levothyroxine (LEVOTHYROXINE), acyclovir (ACYCLOVIR), ezetimibe (EZETIMIBE), hydroxychloroquine (HYDROXYCHLOROQUINE). No other vaccine received in four weeks. The patient experienced adverse events from 20:00 on 26Jan2021. She experienced sore arm, radiated to shoulder, then to back toward backbone, then up back and side of neck. It's very painful. On 07Feb2021 ("today"), her neck pain was better but she had a headache. These events took place ongoing for several days after and since she had the vaccine. It was reported that the events resulted in Disability or permanent damage. The patient did not receive treatment for the events. The outcome of the events was provided as recovering.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Back pain, Headache, Neck pain, Pain in extremity
Clinical narrative: Sore arm; neck pain; radiated to shoulder; radiated to back toward backbone, then up back; headache; This is a spontaneous report from a contactable consumer reporting for herself. A 69-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL9263 and expiry date unknown) on 26Jan2021 18:00 at single does via an unspecified route of administration into her left arm for COVID-19 immunization. Medical history included Lupus, Lyme disease, hypothyroid, Meniere's, and sulfa allergies. The patient had not had COVID prior the vaccination, COVID not tested post the vaccination. Concomitant medication included levothyroxine (LEVOTHYROXINE), acyclovir (ACYCLOVIR), ezetimibe (EZETIMIBE), hydroxychloroquine (HYDROXYCHLOROQUINE). No other vaccine received in four weeks. The patient experienced adverse events from 20:00 on 26Jan2021. She experienced sore arm, radiated to shoulder, then to back toward backbone, then up back and side of neck. It's very painful. On 07Feb2021 ("today"), her neck pain was better but she had a headache. These events took place ongoing for several days after and since she had the vaccine. It was reported that the events resulted in Disability or permanent damage. The patient did not receive treatment for the events. The outcome of the events was provided as recovering.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Blood glucose increased, CSF glucose increased, Dizziness, Dry eye
Clinical narrative: 1/10/2021-Approximatley 34 hours after vaccination developed left facial numbness followed by severe dysequilibrium 5 hours later.   1/11/2021-left facial numbness and dysequilbrium significantly worse along with severe rotary nystagmus in the left eye.  Had appointment with primary care and then ENT , who started me on prednisone 30 mg and antivert.  ENT refered me to Neurology.  Neurology ordered MRI/MRA that night and increased my prednisone to 60mg/day for 5 days followed by a taper over next five days. Currently,  Symptoms of dysequilibrium and numbness have not subsided, on a second course of prednisone 60 mg/day for 3 days followed by taper. MD , Neurologist, provided Diagnosis  of vaccine induced polyneuropathy affecting cranial nerves 5 and 8.  Since the onset on January 10, Cannot work(physician/anesthesiologist) , drive, or perform minor tasks due to the severity of the symptoms.    Symptoms during 1/10/21-1/17-21, bed-ridden, slept 18-20 hours/day, could not walk without assistance-would fall to the left, could not read, nystagmus of left eye, had to keep eyes closed due to severe vertigo/dysequilibrium, nausea.    1/18/21-1/24/21 slight improvement in disequilibrium/able to walk, no change in facial numbness severity , started on 100 mg gabapentin at night, and low dose valium 1.25 mg to 2.5 mg to help with dysequilibrium   1/25/21-1/29/21 50% improvement in facial numbness, began vestibular PT, slow improvement in dysequilibrium and ability to walk and read   1/30/21 Symptoms worsened again, facial numbness returned, dysequilibrium returned to its original severity, difficulty reading/focusing  2/1/21 Followed up with Dr, started another prednisone 60mg/day for 3 days, followed by taper over the next 5 days     2/4/21 Left Facial numbness not improved, dysequilibrium still severe, having difficulty focusing and reading
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Extraocular muscle paresis, Full blood count, Gait disturbance, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: 1/10/2021-Approximatley 34 hours after vaccination developed left facial numbness followed by severe dysequilibrium 5 hours later.   1/11/2021-left facial numbness and dysequilbrium significantly worse along with severe rotary nystagmus in the left eye.  Had appointment with primary care and then ENT , who started me on prednisone 30 mg and antivert.  ENT refered me to Neurology.  Neurology ordered MRI/MRA that night and increased my prednisone to 60mg/day for 5 days followed by a taper over next five days. Currently,  Symptoms of dysequilibrium and numbness have not subsided, on a second course of prednisone 60 mg/day for 3 days followed by taper. MD , Neurologist, provided Diagnosis  of vaccine induced polyneuropathy affecting cranial nerves 5 and 8.  Since the onset on January 10, Cannot work(physician/anesthesiologist) , drive, or perform minor tasks due to the severity of the symptoms.    Symptoms during 1/10/21-1/17-21, bed-ridden, slept 18-20 hours/day, could not walk without assistance-would fall to the left, could not read, nystagmus of left eye, had to keep eyes closed due to severe vertigo/dysequilibrium, nausea.    1/18/21-1/24/21 slight improvement in disequilibrium/able to walk, no change in facial numbness severity , started on 100 mg gabapentin at night, and low dose valium 1.25 mg to 2.5 mg to help with dysequilibrium   1/25/21-1/29/21 50% improvement in facial numbness, began vestibular PT, slow improvement in dysequilibrium and ability to walk and read   1/30/21 Symptoms worsened again, facial numbness returned, dysequilibrium returned to its original severity, difficulty reading/focusing  2/1/21 Followed up with Dr, started another prednisone 60mg/day for 3 days, followed by taper over the next 5 days     2/4/21 Left Facial numbness not improved, dysequilibrium still severe, having difficulty focusing and reading
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Impaired driving ability, Lumbar puncture, Magnetic resonance imaging brain, Magnetic resonance imaging brain normal, Neutrophil count
Clinical narrative: 1/10/2021-Approximatley 34 hours after vaccination developed left facial numbness followed by severe dysequilibrium 5 hours later.   1/11/2021-left facial numbness and dysequilbrium significantly worse along with severe rotary nystagmus in the left eye.  Had appointment with primary care and then ENT , who started me on prednisone 30 mg and antivert.  ENT refered me to Neurology.  Neurology ordered MRI/MRA that night and increased my prednisone to 60mg/day for 5 days followed by a taper over next five days. Currently,  Symptoms of dysequilibrium and numbness have not subsided, on a second course of prednisone 60 mg/day for 3 days followed by taper. MD , Neurologist, provided Diagnosis  of vaccine induced polyneuropathy affecting cranial nerves 5 and 8.  Since the onset on January 10, Cannot work(physician/anesthesiologist) , drive, or perform minor tasks due to the severity of the symptoms.    Symptoms during 1/10/21-1/17-21, bed-ridden, slept 18-20 hours/day, could not walk without assistance-would fall to the left, could not read, nystagmus of left eye, had to keep eyes closed due to severe vertigo/dysequilibrium, nausea.    1/18/21-1/24/21 slight improvement in disequilibrium/able to walk, no change in facial numbness severity , started on 100 mg gabapentin at night, and low dose valium 1.25 mg to 2.5 mg to help with dysequilibrium   1/25/21-1/29/21 50% improvement in facial numbness, began vestibular PT, slow improvement in dysequilibrium and ability to walk and read   1/30/21 Symptoms worsened again, facial numbness returned, dysequilibrium returned to its original severity, difficulty reading/focusing  2/1/21 Followed up with Dr, started another prednisone 60mg/day for 3 days, followed by taper over the next 5 days     2/4/21 Left Facial numbness not improved, dysequilibrium still severe, having difficulty focusing and reading
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Neutrophil count decreased, Pyrexia, Specialist consultation, Vertigo, White blood cell count increased
Clinical narrative: 1/10/2021-Approximatley 34 hours after vaccination developed left facial numbness followed by severe dysequilibrium 5 hours later.   1/11/2021-left facial numbness and dysequilbrium significantly worse along with severe rotary nystagmus in the left eye.  Had appointment with primary care and then ENT , who started me on prednisone 30 mg and antivert.  ENT refered me to Neurology.  Neurology ordered MRI/MRA that night and increased my prednisone to 60mg/day for 5 days followed by a taper over next five days. Currently,  Symptoms of dysequilibrium and numbness have not subsided, on a second course of prednisone 60 mg/day for 3 days followed by taper. MD , Neurologist, provided Diagnosis  of vaccine induced polyneuropathy affecting cranial nerves 5 and 8.  Since the onset on January 10, Cannot work(physician/anesthesiologist) , drive, or perform minor tasks due to the severity of the symptoms.    Symptoms during 1/10/21-1/17-21, bed-ridden, slept 18-20 hours/day, could not walk without assistance-would fall to the left, could not read, nystagmus of left eye, had to keep eyes closed due to severe vertigo/dysequilibrium, nausea.    1/18/21-1/24/21 slight improvement in disequilibrium/able to walk, no change in facial numbness severity , started on 100 mg gabapentin at night, and low dose valium 1.25 mg to 2.5 mg to help with dysequilibrium   1/25/21-1/29/21 50% improvement in facial numbness, began vestibular PT, slow improvement in dysequilibrium and ability to walk and read   1/30/21 Symptoms worsened again, facial numbness returned, dysequilibrium returned to its original severity, difficulty reading/focusing  2/1/21 Followed up with Dr, started another prednisone 60mg/day for 3 days, followed by taper over the next 5 days     2/4/21 Left Facial numbness not improved, dysequilibrium still severe, having difficulty focusing and reading
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram normal, Audiogram normal, Balance disorder, Blood thyroid stimulating hormone normal, C-reactive protein normal
Clinical narrative: 1/10/2021-Approximatley 34 hours after vaccination developed left facial numbness followed by severe dysequilibrium 5 hours later.   1/11/2021-left facial numbness and dysequilbrium significantly worse along with severe rotary nystagmus in the left eye.  Had appointment with primary care and then ENT , who started me on prednisone 30 mg and antivert.  ENT refered me to Neurology.  Neurology ordered MRI/MRA that night and increased my prednisone to 60mg/day for 5 days followed by a taper over next five days. Currently,  Symptoms of dysequilibrium and numbness have not subsided, on a second course of prednisone 60 mg/day for 3 days followed by taper. MD , Neurologist, provided Diagnosis  of vaccine induced polyneuropathy affecting cranial nerves 5 and 8.  Since the onset on January 10, Cannot work(physician/anesthesiologist) , drive, or perform minor tasks due to the severity of the symptoms.    Symptoms during 1/10/21-1/17-21, bed-ridden, slept 18-20 hours/day, could not walk without assistance-would fall to the left, could not read, nystagmus of left eye, had to keep eyes closed due to severe vertigo/dysequilibrium, nausea.    1/18/21-1/24/21 slight improvement in disequilibrium/able to walk, no change in facial numbness severity , started on 100 mg gabapentin at night, and low dose valium 1.25 mg to 2.5 mg to help with dysequilibrium   1/25/21-1/29/21 50% improvement in facial numbness, began vestibular PT, slow improvement in dysequilibrium and ability to walk and read   1/30/21 Symptoms worsened again, facial numbness returned, dysequilibrium returned to its original severity, difficulty reading/focusing  2/1/21 Followed up with Dr, started another prednisone 60mg/day for 3 days, followed by taper over the next 5 days     2/4/21 Left Facial numbness not improved, dysequilibrium still severe, having difficulty focusing and reading
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: CSF culture negative, Full blood count normal, Gait disturbance, Hypersomnia, Hypoaesthesia
Clinical narrative: 1/10/2021-Approximatley 34 hours after vaccination developed left facial numbness followed by severe dysequilibrium 5 hours later.   1/11/2021-left facial numbness and dysequilbrium significantly worse along with severe rotary nystagmus in the left eye.  Had appointment with primary care and then ENT , who started me on prednisone 30 mg and antivert.  ENT refered me to Neurology.  Neurology ordered MRI/MRA that night and increased my prednisone to 60mg/day for 5 days followed by a taper over next five days. Currently,  Symptoms of dysequilibrium and numbness have not subsided, on a second course of prednisone 60 mg/day for 3 days followed by taper. MD , Neurologist, provided Diagnosis  of vaccine induced polyneuropathy affecting cranial nerves 5 and 8.  Since the onset on January 10, Cannot work(physician/anesthesiologist) , drive, or perform minor tasks due to the severity of the symptoms.    Symptoms during 1/10/21-1/17-21, bed-ridden, slept 18-20 hours/day, could not walk without assistance-would fall to the left, could not read, nystagmus of left eye, had to keep eyes closed due to severe vertigo/dysequilibrium, nausea.    1/18/21-1/24/21 slight improvement in disequilibrium/able to walk, no change in facial numbness severity , started on 100 mg gabapentin at night, and low dose valium 1.25 mg to 2.5 mg to help with dysequilibrium   1/25/21-1/29/21 50% improvement in facial numbness, began vestibular PT, slow improvement in dysequilibrium and ability to walk and read   1/30/21 Symptoms worsened again, facial numbness returned, dysequilibrium returned to its original severity, difficulty reading/focusing  2/1/21 Followed up with Dr, started another prednisone 60mg/day for 3 days, followed by taper over the next 5 days     2/4/21 Left Facial numbness not improved, dysequilibrium still severe, having difficulty focusing and reading
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Impaired driving ability, Impaired work ability, Loss of personal independence in daily activities, Lumbar puncture normal, Magnetic resonance imaging normal
Clinical narrative: 1/10/2021-Approximatley 34 hours after vaccination developed left facial numbness followed by severe dysequilibrium 5 hours later.   1/11/2021-left facial numbness and dysequilbrium significantly worse along with severe rotary nystagmus in the left eye.  Had appointment with primary care and then ENT , who started me on prednisone 30 mg and antivert.  ENT refered me to Neurology.  Neurology ordered MRI/MRA that night and increased my prednisone to 60mg/day for 5 days followed by a taper over next five days. Currently,  Symptoms of dysequilibrium and numbness have not subsided, on a second course of prednisone 60 mg/day for 3 days followed by taper. MD , Neurologist, provided Diagnosis  of vaccine induced polyneuropathy affecting cranial nerves 5 and 8.  Since the onset on January 10, Cannot work(physician/anesthesiologist) , drive, or perform minor tasks due to the severity of the symptoms.    Symptoms during 1/10/21-1/17-21, bed-ridden, slept 18-20 hours/day, could not walk without assistance-would fall to the left, could not read, nystagmus of left eye, had to keep eyes closed due to severe vertigo/dysequilibrium, nausea.    1/18/21-1/24/21 slight improvement in disequilibrium/able to walk, no change in facial numbness severity , started on 100 mg gabapentin at night, and low dose valium 1.25 mg to 2.5 mg to help with dysequilibrium   1/25/21-1/29/21 50% improvement in facial numbness, began vestibular PT, slow improvement in dysequilibrium and ability to walk and read   1/30/21 Symptoms worsened again, facial numbness returned, dysequilibrium returned to its original severity, difficulty reading/focusing  2/1/21 Followed up with Dr, started another prednisone 60mg/day for 3 days, followed by taper over the next 5 days     2/4/21 Left Facial numbness not improved, dysequilibrium still severe, having difficulty focusing and reading